ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Aspirin / administration & dosage
ABC
Original Article

Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study

Rafael Caire de Oliveira dos Santos et al. Alessandra Carvalho Goulart Alan Loureiro Xavier Kisukuri Rodrigo Martins Brandão … Debora Sitnik Henrique Lane Staniak Marcio Sommer Bittencourt Paulo Andrade Lotufo Isabela Martins Bensenor Itamar de Souza Santos

Abstract

Background:

To the best of our knowledge, there are no studies evaluating the influence of the unit of the first contact on the frequency and time of pharmacological treatment during an acute coronary syndrome (ACS) event.

Objectives:

The main objective was to investigate if the unit of first contact influenced the frequency and time of aspirin treatment in the Strategy of Registry of Acute Coronary Syndrome (ERICO) study.

Methods:

We analyzed the pharmacological treatment time in 830 ERICO participants – 700 individuals for whom the hospital was the unit of first contact and 130 who initially sought primary care units. We built logistic regression models to study whether the unit of first contact was associated with a treatment time of less than three hours.

Results:

Individuals who went to primary care units received the first aspirin dose in those units in 75.6% of the cases. The remaining 24.4% received aspirin at the hospital. Despite this finding, individuals from primary care still had aspirin administered within three hours more frequently than those who went to the hospital (76.8% vs 52.6%; p<0.001 and 100% vs. 70.7%; p=0.001 for non ST-elevation ACS and ST-elevation myocardial infarction, respectively). In adjusted models, individuals coming from primary care were more likely to receive aspirin more quickly (odds ratio: 3.66; 95% confidence interval: 2.06-6.51).

Conclusions:

In our setting, individuals from primary care were more likely to receive aspirin earlier. Enhancing the ability of primary care units to provide early treatment and safe transportation may be beneficial in similar settings.

  • Acute Coronary Syndrome / mortality
  • Anticoagulants, Time-to-Treatment
  • Aspirin / administration & dosage
  • Cohort Studies
  • Primary Health Care
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
01/10/2016 DOI: 10.5935/abc.20160138
Figure 1
ABC
Review Article

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Pedro Gabriel Melo de Barros e Silva et al. Henrique Barbosa Ribeiro Antônio Claudio do Amaral Baruzzi Expedito Eustáquio Ribeiro da Silva

Abstract

Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding the best time to start the second antiplatelet agent. The evidences are conflicting, and after more than a decade using clopidogrel in this scenario, benefits from the routine pretreatment, i.e. without knowing the coronary anatomy, with dual antiplatelet therapy remain uncertain. The recommendation for the upfront treatment with clopidogrel in NSTE-ACS is based on the reduction of non-fatal events in studies that used the conservative strategy with eventual invasive stratification, after many days of the acute event. This approach is different from the current management of these patients, considering the established benefits from the early invasive strategy, especially in moderate to high-risk patients. The only randomized study to date that specifically tested the pretreatment in NSTE-ACS in the context of early invasive strategy, used prasugrel, and it did not show any benefit in reducing ischemic events with pretreatment. On the contrary, its administration increased the risk of bleeding events. This study has brought the pretreatment again into discussion, and led to changes in recent guidelines of the American and European cardiology societies. In this paper, the authors review the main evidence of the pretreatment with dual antiplatelet therapy in NSTE-ACS.

  • Acute coronary syndrome/therapy
  • Aspirin / administration & dosage
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors / administration & dosage
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
01/03/2016 DOI: 10.5935/abc.20160042

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Santos RCO, Goulart AC, Kisukuri ALX, Brandão RM, Sitnik D, Staniak HL, Bittencourt MS, et al. Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study. Arquivos Brasileiros de Cardiologia 2016;107(4):323-30.

Electronic Document Format (ABNT)

Santos, Rafael Caire de Oliveira dos; Goulart, Alessandra Carvalho; Kisukuri, Alan Loureiro Xavier; Brandão, Rodrigo Martins; Sitnik, Debora; Staniak, Henrique Lane; Bittencourt, Marcio Sommer; Lotufo, Paulo Andrade; Bensenor, Isabela Martins; Santos, Itamar de Souza. Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study. Arquivos Brasileiros de Cardiologia, v. 107, n. 4, p. 323-330, Sep. 2016.

Electronic Document Format (APA)

Santos, R. C. O. , Goulart, A. C., Kisukuri, A. L. X., Brandão, R. M., Sitnik, D., Staniak, H. L., Bittencourt, M. S., Lotufo, P. A., Bensenor, I. M., & Santos, I. S. (2016). Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study. Arquivos Brasileiros de Cardiologia, 107(4), 323-330.

Electronic Document Format (ISO)

Santos, Rafael Caire de Oliveira dos and Goulart, Alessandra Carvalho and Kisukuri, Alan Loureiro Xavier and Brandão, Rodrigo Martins and Sitnik, Debora and Staniak, Henrique Lane and Bittencourt, Marcio Sommer and Lotufo, Paulo Andrade and Bensenor, Isabela Martins and Santos, Itamar de Souza. Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study. Arquivos Brasileiros de Cardiologia [online]. 2016, vol. 107, n. 4, [cited 2026-10-14], pp. 323-330. Available from: <https://journals.cardiol.br/en/article/time-to-treatment-of-acute-coronary-syndrome-and-unit-of-first-contact-in-the-erico-study/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Silva PGMB, Ribeiro HB, Baruzzi ACA, Silva EER. When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?. Arquivos Brasileiros de Cardiologia 2016;106(3):236-4.

Electronic Document Format (ABNT)

Silva, Pedro Gabriel Melo de Barros e; Ribeiro, Henrique Barbosa; Baruzzi, Antônio Claudio do Amaral; Silva, Expedito Eustáquio Ribeiro da. When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?. Arquivos Brasileiros de Cardiologia, v. 106, n. 3, p. 236-246, Feb. 2016.

Electronic Document Format (APA)

Silva, P. G. M. B. , Ribeiro, H. B., Baruzzi, A. C. A., & Silva, E. E. R. (2016). When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?. Arquivos Brasileiros de Cardiologia, 106(3), 236-246.

Electronic Document Format (ISO)

Silva, Pedro Gabriel Melo de Barros e and Ribeiro, Henrique Barbosa and Baruzzi, Antônio Claudio do Amaral and Silva, Expedito Eustáquio Ribeiro da. When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?. Arquivos Brasileiros de Cardiologia [online]. 2016, vol. 106, n. 3, [cited 2026-10-14], pp. 236-246. Available from: <https://journals.cardiol.br/en/article/when-is-the-best-time-for-the-second-antiplatelet-agent-in-non-st-elevation-acute-coronary-syndrome/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News